| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 6 months | ₹30,000 | ₹32,364 | +7.88% | |
| 1 year | ₹60,000 | ₹70,289 | +17.15% | |
| 3 years | ₹1,80,000 | ₹2,42,083 | +34.49% | |
| 5 years | ₹3,00,000 | ₹5,18,445 | +72.81% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.32% |
| Divi's Laboratories Ltd | Healthcare | Equity | 9.97% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 6.41% |
| Laurus Labs Ltd | Healthcare | Equity | 6.37% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 5.81% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 5.45% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 4.61% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 3.73% |
| Alkem Laboratories Ltd | Healthcare | Equity | 3.65% |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | Equity | 3.48% |
| Ipca Laboratories Ltd | Healthcare | Equity | 3.33% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 3.23% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 3.19% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 3.05% |
| Onesource Specialty Pharma Ltd | Healthcare | Equity | 3.04% |
| Fortis Healthcare Ltd | Healthcare | Equity | 2.87% |
| Gland Pharma Ltd | Healthcare | Equity | 2.82% |
| Cipla Ltd | Healthcare | Equity | 2.65% |
| Eris Lifesciences Ltd | Healthcare | Equity | 2.27% |
| Lupin Ltd | Healthcare | Equity | 2.20% |
| Mankind Pharma Ltd. | Healthcare | Equity | 2.19% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 2.13% |
| Biocon Ltd | Healthcare | Equity | 1.97% |
| Molbio Diagnostics Ltd. | Healthcare | Equity | 1.69% |
| Symbiotec Pharmalab Ltd. | Healthcare | Equity | 1.66% |
| Neogen Chemicals Ltd | Materials | Equity | 1.41% |
| Deepak Nitrite Ltd | Materials | Equity | 0.39% |
| Repo | Unspecified | Repo | 0.23% |
| Mirae Asset Liquid Fund Direct- Growth | Unspecified | Mutual Fund | 0.01% |
| Narayana Hrudayalaya Ltd | Healthcare | Equity | 0.00% |
| Net Payables | Unspecified | Net Payables | -0.12% |
| Name | 1Y | 3Y | 5Y | All |
|---|---|---|---|---|
| Fund returns | +28.1% | +23.7% | +17.8% | +22.6% |
| Category average (Equity Sectoral) | +20.5% | +23.0% | +17.3% | +17.6% |
| Rank (Equity Sectoral) | 3 | 3 | 3 | -- |